FRANKLIN, Tenn., September 1, 2026 – Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers, today announced the general availability of its GenAI Peer-to-Peer Clinical Synopsis solution. The new capability is available within the company’s existing solution built for physician advisor teams, Dragonfly Advise®, and helps physician advisors prepare to discuss denied cases with health plan medical directors.
Peer-to-peer conversations must often take place within 24 to 72 hours of a denial, leaving physician advisors limited time to review the medical record and prepare the clinical case supporting a patient’s level of care. According to the American Medical Association, nearly half of physicians who do not pursue an appeal cite a lack of time or staff resources, while data compiled by KFF shows that more than 80% of formally appealed denials are ultimately overturned. Xsolis’ new capability scans the medical record for key clinical facts, including laboratory results, vital signs, treatment, and patient progress. It then creates a concise patient overview and day-by-day summary of the clinical severity indicators and medical necessity rationale supporting continued inpatient care. Generated automatically when a peer-to-peer review is escalated within Dragonfly Advise, the summary helps the physician advisor quickly understand the case before speaking with the payer.
“Peer-to-peer reviews are among the most time-sensitive points in the denial process, and physicians are often preparing for them while managing a full clinical and administrative workflow,” said Joan Butters, co-founder and CEO of Xsolis. “By bringing the most relevant clinical facts forward, we can reduce the work required to reconstruct the case, help physician advisors enter the conversation prepared, and surface details that are easy to miss in a complex chart.”
Xsolis has signed agreements with several health system partners to add the GenAI Peer-to-Peer Clinical Synopsis solution to their utilization management and physician advisor workflows, with implementation underway in the coming months.
This launch marks the third generative AI capability Xsolis has introduced within Dragonfly, its AI-powered platform for healthcare providers and health plans. The company previously developed solutions to support appeal letter preparations and streamline initial medical necessity reviews. In a three-month pilot with Beacon Health System, the medical necessity review solution reduced average review time by 68%, from 15 minutes to 4.7 minutes.
The GenAI Peer-to-Peer Clinical Synopsis is available as an add-on capability within Dragonfly Advise and can be enabled at the hospital or facility level. The solution’s next set of enhancements include the ability for Xsolis’ Peer-to-Peer Clinical Synopsis to be consumed within other systems that Physician Advisors utilize for peer-to-peer conversations.
For more information about Dragonfly and Xsolis’ suite of AI-powered solutions, visit www.xsolis.com/solutions.
About Xsolis Xsolis is an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers. Dragonfly®, its AI-driven proprietary platform, is the first and only solution to use real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient, enabling more efficiency across the healthcare system. Xsolis is headquartered in Franklin, Tennessee. For more information, visit www.xsolis.com.